Keßler, A. F., & Ritz, R. (2019). P14.59 Post-Market Surveillance Data of the EMEA region indicate good tolerability of TTFields in WHO Grade III Glioma. Neuro Oncol.
Dyfyniad Arddull ChicagoKeßler, A F., and R. Ritz. "P14.59 Post-Market Surveillance Data of the EMEA Region Indicate Good Tolerability of TTFields in WHO Grade III Glioma." Neuro Oncol 2019.
Dyfyniad MLAKeßler, A F., and R. Ritz. "P14.59 Post-Market Surveillance Data of the EMEA Region Indicate Good Tolerability of TTFields in WHO Grade III Glioma." Neuro Oncol 2019.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.